FisherBroyles News

/FisherBroyles News

Client Alert – CVS Pitches A New Plan to Combat High Drug Prices

CVS Health has introduced a white paper highlighting several new techniques it claims will reduce the cost of drugs (“Current and New Approaches to Making Drugs More Affordable”). CVS determines that these new techniques, together with several approaches already in use, will help patients afford the medications they need (thus ensuring that more people take [...]

RXinsider Thought Leader Videos – What to Expect Regarding the PBMs’ Ongoing War Against Independent Pharmacies?

As part of a Thought Leader Video Series, Anthony Calamunci and Brian Dickerson were interviewed by RXinsider on the status of the Pharmacy industry. Each week FisherBroyles will provide access to the industry specific Q&A interview sessions hosted by RXinsider so you can learn what the newest legal and industry issues are and how to [...]

Client Alert – OIG Issues Advisory Opinion on Provision of Cost-Free Telemedicine Hardware and Services

The Health and Human Services Office of Inspector General (OIG) recently issued Advisory Opinion No. 18-03 (the “Opinion”) on a question regarding the possible application of the Anti-Kickback Statute in a proposed arrangement between a federally qualified health center look-alike (the “Provider”) and a county clinic (the “Clinic”). In the arrangement, the Provider would give, [...]

Client Alert – USTR Unveils Second List of Chinese Goods to Be Hit With Steep Tariffs and Turns Focus to Proposed Third List; Entities Seeking Relief Must Act Soon

Recently, in connection with the quickly and significantly escalating trade war between the United States and China relating to Chinese technology transfer and intellectual property practices found by the Trump Administration in a Section 301 investigation to be unfair to U.S. companies (the “China 301 Investigation”), the U.S. Trade Representative (“USTR”) has:  (1) promulgated the [...]

RXinsider Thought Leader Videos – Implications of FWA and False Claims

As part of a Thought Leader Video Series, Anthony Calamunci and Brian Dickerson were interviewed by RXinsider on the status of the Pharmacy industry. Each week FisherBroyles will provide access to the industry specific Q&A interview sessions hosted by RXinsider so you can learn what the newest legal and industry issues are and how to [...]

Fisher Broyles Partner Beth-ann Roth Quoted in Financial Times Article, “The Rise of Celebrity Financial Endorsements”

Partner Beth-ann Roth quoted in August 4, 2018 Financial Times article, "The rise of celebrity financial endorsements: Companies are turning to social media stars to publicise complex products, from home improvement loans to cryptocurrencies." Read full article.

Client Alert – Fintechs are Now Eligible to Apply for National Bank Licenses: Should They?

Effective July 31, 2018, the Office of the Comptroller of the Currency (“OCC”) officially opened the door for non-depository financial technology (“Fintech”) companies to apply for a special federal banking license. In the Release (NR 2018-74; the “Release”), Joseph M. Otting, the Comptroller, cited the broad regulatory and supervisory authority given to the OCC under [...]

RXinsider is Proud to Present FisherBroyles as a Thought Leader in Health and Pharmacy Law

In FisherBroyles' NEW Thought Leader Video Series, Brian E. Dickerson, JD, Partner, and Anthony J. Calamunci, JD, CFE, Partner, discuss health and pharmacy law and how they can assist in multifaceted and complex issues within the industry. Topics include: The importance of seeking legal counsel for compliance programs. Best practices for affiliating with outside entities [...]

Partner R. Mark Halligan selected on behalf of the United States for the award of Innovation Asset Management by Corporate LiveWire Global Awards 2018

In his quest to make the protection of trade secrets more effective, Mark co-invented the new Trade Secret Examiner® software platform that was commercially deployed in August 2017 by The Trade Secret Office Inc. This easy to use software automates and blockchains trade secret asset management to validate the existence of trade secrets; inventory and [...]